PMID- 2553845 OWN - NLM STAT- MEDLINE DCOM- 19891130 LR - 20190903 IS - 0954-6820 (Print) IS - 0954-6820 (Linking) VI - 226 IP - 4 DP - 1989 Oct TI - High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril. PG - 257-60 AB - Eighteen patients with dilated cardiomyopathy (three female, mean age 57 years), were treated for 48 weeks with enalapril added to digoxin and diuretic therapy for congestive heart failure of New York Heart Association (NYHA) functional class II (three patients). III (eight patients) and IV (seven patients), respectively. Serum levels of erythropoietin (EPO) were raised at the start (37 +/- 12.8 pmol 1(-1); mean +/- SD) and were normalized during enalapril treatment (17.5 +/- 9.9 pmol 1(-1) at 48 weeks; P less than 0.001). Serum EPO correlated at the start with NYHA functional class (r = 0.68; P less than 0.05). Normalization of elevated serum EPO concentrations during treatment with enalapril paralleled clinical and haemodynamic improvement, and probably reflected relief from renal hypoxia. FAU - Fyhrquist, F AU - Fyhrquist F AD - Minerva Institute for Medical Research, Helsinki, Finland. FAU - Karppinen, K AU - Karppinen K FAU - Honkanen, T AU - Honkanen T FAU - Saijonmaa, O AU - Saijonmaa O FAU - Rosenlof, K AU - Rosenlof K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Intern Med JT - Journal of internal medicine JID - 8904841 RN - 11096-26-7 (Erythropoietin) RN - 69PN84IO1A (Enalapril) SB - IM MH - Adult MH - Aged MH - Enalapril/*therapeutic use MH - Erythropoietin/*blood MH - Female MH - Heart Failure/blood/*drug therapy MH - Humans MH - Male MH - Middle Aged EDAT- 1989/10/01 00:00 MHDA- 1989/10/01 00:01 CRDT- 1989/10/01 00:00 PHST- 1989/10/01 00:00 [pubmed] PHST- 1989/10/01 00:01 [medline] PHST- 1989/10/01 00:00 [entrez] AID - 10.1111/j.1365-2796.1989.tb01390.x [doi] PST - ppublish SO - J Intern Med. 1989 Oct;226(4):257-60. doi: 10.1111/j.1365-2796.1989.tb01390.x.